Mark Sabag Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

Mark Sabag is EVP, International Markets of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 382,590 shares of TEVA, which is worth approximately $6.39 Million. The most recent transaction as insider was on Mar 05, 2024, when has been sold 100,000 shares (Ordinary Shares) at a price of $13.52 per share, resulting in proceeds of $1,352,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 383K

0% 3M change

18.93% 12M change

Total Value Held $6.39 Million

Mark Sabag Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2024	SELL Open market or private sale	$1,352,000 $13.52 p/Share	100,000 Reduced 20.72%	382,590 Ordinary Shares
Mar 05 2024	BUY Exercise of conversion of derivative security	-	81,897 Added 14.51%	482,590 Ordinary Shares
Mar 04 2024	BUY Exercise of conversion of derivative security	-	33,512 Added 7.72%	400,693 Ordinary Shares
Mar 03 2024	BUY Exercise of conversion of derivative security	-	24,900 Added 6.35%	367,181 Ordinary Shares
Feb 28 2024	BUY Exercise of conversion of derivative security	-	20,599 Added 5.68%	342,281 Ordinary Shares
Mar 05 2023	BUY Exercise of conversion of derivative security	-	23,764 Added 6.88%	321,682 Ordinary Shares
Mar 04 2023	BUY Exercise of conversion of derivative security	-	49,433 Added 14.23%	297,918 Ordinary Shares
Feb 28 2023	BUY Exercise of conversion of derivative security	-	70,840 Added 22.18%	248,485 Ordinary Shares
Mar 05 2022	BUY Exercise of conversion of derivative security	-	23,764 Added 11.8%	177,645 Ordinary Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	-	59,278 Added 27.81%	153,881 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	20,598 Added 17.88%	94,603 Ordinary Shares
Feb 09 2022	BUY Exercise of conversion of derivative security	-	15,523 Added 17.34%	74,005 Ordinary Shares
May 11 2021	BUY Exercise of conversion of derivative security	-	37,884 Added 39.31%	58,482 Ordinary Shares
Mar 16 2021	SELL Open market or private sale	$1,427,678 $11.22 p/Share	127,244 Reduced 86.07%	20,598 Ordinary Shares
Mar 04 2021	BUY Exercise of conversion of derivative security	-	15,920 Added 9.72%	147,842 Ordinary Shares
Feb 28 2021	BUY Exercise of conversion of derivative security	-	20,598 Added 13.51%	131,922 Ordinary Shares
Feb 14 2021	BUY Exercise of conversion of derivative security	-	5,712 Added 4.88%	111,324 Ordinary Shares
Feb 09 2021	BUY Grant, award, or other acquisition	-	65,339 Added 38.22%	105,612 Ordinary Shares
Feb 09 2021	BUY Exercise of conversion of derivative security	-	15,523 Added 27.82%	40,273 Ordinary Shares

Mark Sabag

EVP, International Markets

Tel Aviv, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Value

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA

Account